Sep 26 |
CASI Pharmaceuticals (NASDAQ:CASI) shareholders are still up 129% over 1 year despite pulling back 22% in the past week
|
Sep 4 |
CASI PHARMACEUTICALS TO PARTICIPATE IN THE 2024 H.C. WAINWRIGHT GLOBAL INVESTMENT CONFERENCE
|
Jul 8 |
CASI Pharmaceuticals appoints Daniel Lang, MD as CFO
|
Jul 8 |
CASI Pharmaceuticals announces appointment of Daniel Lang, MD as CFO and SVP
|
Jun 26 |
CASI Pharmaceuticals jumps after receiving acquisition proposal for entire China business
|
Jun 26 |
CASI Pharmaceuticals Announces Plan To Submit IND Application For CID-103, an Anti-CD 38 Antibody in Antibody-Mediated Rejection, and Receipt of a Non-Binding Proposal to Acquire Entire China Business of the Company
|
Jun 26 |
CASI Pharmaceuticals Announces $15 Million Private Placement Financing by Venrock Healthcare Capital Partners, Foresite Capital, Panacea Venture and Dr. Wei-Wu He
|
Apr 8 |
CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS
|